Insider filing
Traded Nov 9 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 9, 2026 · Filed Nov 12, 2026
AbbVie's CHIEF COMMERCIAL OFFICER sold $11.9M of AbbVie shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$11,925,738
Shares × reported transaction price
10 days after results of Oct 30, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $293.30 on Nov 9, 2026, within 1% of its 52-week high, after a 10% rise over the previous 30 trading days
52-week range $197.38 (Apr 27, 2026) to $294.89 (Oct 30, 2026), 98% of the way up, from 251 adjusted closes. 30 trading days earlier: $266.28 on Sep 28, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Jeffrey Ryan Stewart's largest sale of ABBV in their filings since 2020
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
FDA approved Skyrizi on Oct 23, 2026, 17 days before this trade.
New use approved (efficacy supplement). Active ingredient: Risankizumab-Rzaa. From openFDA. Dates only; no link between the two is implied
Insider filing
Traded Nov 9 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Nov 9 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Nov 12 · filed the same day
Gift or transfer — classified separately from trades.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.